Insider trade

Officer sold ~$105K of DGX shares in the open market

Traded Aug 28, 2026 · Filed Aug 31, 2026

~$105K
Reported value · 430 sh @ $244.51: 38K
Holds after · shares reported: −4.3%
stock since the trade · S&P 500 +0.7%, $242.76 → $232.22 on Oct 5

Why it stands out

Quest Diagnostics's SVP & General Counsel sold $105K of Quest Diagnostics shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 28, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 31, 2026

Officer$100K–$500KPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$105,141

Shares × reported transaction price

Timing vs results

36 days after results of Jul 23, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $242.76 on Aug 28, 2026, within 1% of its 52-week high, after a 15% rise over the previous 30 trading days

52-week range $173.49 (Jan 5, 2026) to $245.00 (Aug 26, 2026), 97% of the way up, from 251 adjusted closes. 30 trading days earlier: $210.68 on Jul 17, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	−0.3%	+0.6%	−0.8%
30 days	−2.2%	+0.3%	−2.5%

Past results only. Not a forecast.

Source receipt

Record ID: 0001022079-26-000089
Filed / recorded: Aug 31, 2026, 8:37 PM UTC
Added to OQRO: Oct 2, 2026, 12:28 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: QUEST DIAGNOSTICS INC
Issuer CIK: 1022079
Ticker: DGX
Reporting person: Michael E Prevoznik
Relationship: Officer
Officer title: SVP & General Counsel
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Aug 28, 2026
Transaction code: S
Shares / units: 430
Price per share: $244.51
Acquired / disposed: Disposed (D)
Shares owned after: 37,557
Ownership form: Direct
Amendment: No

Footnotes from the filing

This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
This transaction was executed in multiple trades at prices ranging from $244.280 to $245.247. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Around the same time

CEO sold ~$2.43M of Quest Diagnostics

Scheduled in advance5w ago

23KShares · @ $112.17

5w ago

Derivative exercise or conversion — not an open-market buy.

More Official record

Officer sold ~$3.89M of Quest Diagnostics

Scheduled in advance5w ago